These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 27252397)

  • 1. Aminoglycosides: An Overview.
    Krause KM; Serio AW; Kane TR; Connolly LE
    Cold Spring Harb Perspect Med; 2016 Jun; 6(6):. PubMed ID: 27252397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation.
    Serio AW; Keepers T; Andrews L; Krause KM
    EcoSal Plus; 2018 Nov; 8(1):. PubMed ID: 30447062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.
    Doi Y; Arakawa Y
    Clin Infect Dis; 2007 Jul; 45(1):88-94. PubMed ID: 17554708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
    Sanfilippo CM; Morrissey I; Janes R; Morris TW
    Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycosides: Time for the Resurrection of a Neglected Class of Antibacterials?
    Böttger EC; Crich D
    ACS Infect Dis; 2020 Feb; 6(2):168-172. PubMed ID: 31855407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.
    Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB
    J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread dissemination of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase and ArmA 16S ribosomal RNA methylase in a Bulgarian university hospital.
    Strateva T; Markova B; Marteva-Proevska Y; Ivanova D; Mitov I
    Braz J Infect Dis; 2012; 16(3):307-10. PubMed ID: 22729206
    [No Abstract]   [Full Text] [Related]  

  • 9. A mini-review: environmental and metabolic factors affecting aminoglycoside efficacy.
    Webster CM; Shepherd M
    World J Microbiol Biotechnol; 2022 Nov; 39(1):7. PubMed ID: 36350431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
    Potron A; Poirel L; Nordmann P
    Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
    Zimmermann L; Das I; Désiré J; Sautrey G; Barros R S V; El Khoury M; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2016 Oct; 59(20):9350-9369. PubMed ID: 27690420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Integrons and Sulfonamide Resistance Genes among Bacteria from Drinking Water Distribution Systems in Southwestern Nigeria.
    Adesoji AT; Ogunjobi AA; Olatoye IO
    Chemotherapy; 2017; 62(1):34-42. PubMed ID: 27322615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.
    Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T
    Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA as a drug target: the case of aminoglycosides.
    Vicens Q; Westhof E
    Chembiochem; 2003 Oct; 4(10):1018-23. PubMed ID: 14523919
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglycoside antibiotics in the 21st century.
    Becker B; Cooper MA
    ACS Chem Biol; 2013 Jan; 8(1):105-15. PubMed ID: 23110460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid-mediated 16S rRNA methylases among extended-spectrum-beta-lactamase-producing Salmonella enterica Senftenberg isolates from Algeria.
    Naas T; Bentchouala C; Lima S; Lezzar A; Smati F; Scheftel JM; Nordmann P
    J Antimicrob Chemother; 2009 Oct; 64(4):866-8. PubMed ID: 19700474
    [No Abstract]   [Full Text] [Related]  

  • 20. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.